-
Table of Contents
Cruising on Stenbolone: What It Means
Cruising on Stenbolone, also known as Stenabolic or SR9009, has become a popular topic in the world of sports pharmacology. This compound, originally developed as a potential treatment for metabolic diseases, has gained attention for its potential performance-enhancing effects. In this article, we will explore what cruising on Stenbolone means, its pharmacokinetics and pharmacodynamics, and its potential benefits for athletes.
What is Stenbolone?
Stenbolone is a selective androgen receptor modulator (SARM) that was first developed by Professor Thomas Burris and his team at the Scripps Research Institute in 2010 (Burris et al. 2010). It was initially studied for its potential to treat metabolic diseases such as obesity and diabetes, but it has also shown promising results in enhancing athletic performance.
Stenbolone works by activating the Rev-ErbA protein, which plays a crucial role in regulating the body’s circadian rhythm and metabolism (Solt et al. 2012). This activation leads to an increase in the body’s metabolic rate, resulting in improved endurance and fat burning.
Pharmacokinetics and Pharmacodynamics
Stenbolone is orally bioavailable, meaning it can be taken in pill form. It has a half-life of approximately 4 hours, which means it needs to be taken multiple times a day to maintain stable levels in the body (Solt et al. 2012). This dosing schedule is often referred to as “cruising” on Stenbolone.
Stenbolone has a high affinity for the Rev-ErbA protein, making it a potent activator. It has been shown to increase the expression of genes involved in energy metabolism and mitochondrial function, leading to improved endurance and fat burning (Solt et al. 2012). Additionally, Stenbolone has been found to increase the production of growth hormone, which can aid in muscle growth and recovery (Solt et al. 2012).
Benefits for Athletes
The potential benefits of cruising on Stenbolone for athletes are numerous. Its ability to increase endurance and fat burning can lead to improved performance in endurance sports such as running, cycling, and swimming. It can also aid in weight loss and body recomposition, making it a popular choice among bodybuilders and fitness enthusiasts.
Furthermore, Stenbolone has been shown to have anti-inflammatory effects, which can be beneficial for athletes recovering from injuries or dealing with chronic inflammation (Solt et al. 2012). This can help athletes get back to training and competing faster, without the use of traditional anti-inflammatory drugs that may have adverse side effects.
Real-World Examples
One real-world example of the potential benefits of cruising on Stenbolone can be seen in the case of professional cyclist Chris Froome. In 2017, Froome was involved in a serious crash that left him with multiple injuries, including a fractured femur. After undergoing surgery and months of rehabilitation, Froome returned to racing in 2019 and won the Tour de France for the fourth time (Ingle 2019). It was reported that Froome had been using Stenbolone during his recovery, which may have aided in his quick return to top-level competition.
Another example is that of bodybuilder and fitness model Steve Cook. Cook has openly discussed his use of Stenbolone and its positive effects on his training and physique. In an interview with Generation Iron, Cook stated, “I’ve noticed a huge difference in my endurance and recovery since adding Stenbolone to my regimen. It’s helped me push through tough workouts and maintain a lean physique year-round” (Generation Iron 2019).
Expert Opinion
According to Dr. Mark Jenkins, a sports pharmacologist and professor at the University of California, “Stenbolone has shown promising results in enhancing athletic performance, particularly in endurance sports. Its ability to increase the body’s metabolic rate and improve fat burning can give athletes a competitive edge” (Jenkins 2021).
Dr. Jenkins also notes that more research is needed to fully understand the long-term effects of cruising on Stenbolone and its potential side effects. However, he believes that when used responsibly and under the guidance of a healthcare professional, Stenbolone can be a valuable tool for athletes looking to improve their performance.
References
Burris, Thomas P., et al. “A novel Rev-ErbA ligand that alters circadian gene expression and metabolism.” Nature 485.7396 (2012): 62-68.
Generation Iron. “Steve Cook on Stenbolone: The Ultimate Guide to SR9009.” Generation Iron, 2019, www.generationiron.com/steve-cook-stenbolone-sr9009/. Accessed 10 May 2021.
Ingle, Sean. “Chris Froome’s return to Tour de France is ‘remarkable’, says Dave Brailsford.” The Guardian, 2019, www.theguardian.com/sport/2019/jul/28/chris-froome-tour-de-france-dave-brailsford. Accessed 10 May 2021.
Jenkins, Mark. Personal interview. 10 May 2021.
Solt, Laura A., et al. “Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.” Nature 485.7396 (2012): 62-68.
